UnitedHealth Group announced a new CEO Tuesday, an unexpected change at the company that has been embroiled in chaos since the fatal shooting of then-CEO Brian Thompson in December. Former CEO Andrew Witty stepped down for “personal reasons,

The executive earlier caused public outrage when he defended the insurance giant’s practice of denying health care claims.

MIDTOWN - Brian Thompson, the CEO of UnitedHealthcare, was shot and killed outside a midtown Manhattan hotel Wednesday morning in what police are calling a targeted attack. Thompson, 50 ...

UnitedHealth Group’s CEO announced his shock resignation on Tuesday less than a week after alleged UnitedHealthcare shooter Luigi Mangione’s legal defense fund surpassed $1 million in donations. Andrew Witty has managed the conglomerate since 2021 and handled the fallout after 27-year-old Mangione allegedly shot UnitedHealthcare CEO Brian Thompson in broad daylight in Manhattan last December.

UnitedHealth Group was sued Wednesday for allegedly concealing how backlash from the killing of a top executive was damaging its business, causing its stock to nosedive after the insurer lowered its 2025 outlook.

The lawsuit, which seeks class action status, alleges that UnitedHealth and its executives didn’t properly warn investors about how the killing of UnitedHealthcare CEO Brian Thompson would affect its business.

Stephen Hemsley will return to running the healthcare giant he helped build, succeeding CEO Andrew Witty.

The tactics were becoming "increasingly controversial," the complaint said, especially after the death of former UnitedHealthcare CEO Brian Thompson. Though widely condemned, his killing also ...

UnitedHealth CEO Andrew Witty is stepping down for personal reasons and the nation's largest health insurer suspended its full-year financial outlook due to higher-than-expected medical costs.Video above: Luigi Mangione indicted in UnitedHealth CEO Brian Thompson deathUnitedHealth cut its 2025 forecast last month following its first quarterly earnings miss in more than a decade.

A stock slide and investigations will put Stephen Hemsley’s credibility with investors to the test.